Numerous trials have been conducted to assess the utility of self-monitoring of blood glucose (SMBG) in noninsulin-treated type 2 diabetic (T2DM) patients. Although recent meta-analyses support the benefits of SMBG, the clinical utility of SMBG in this population remains controversial due to a lack of large, randomized controlled trials. Much of the skepticism regarding SMBG in noninsulin-treated T2DM may stem from a misapplication or misunderstanding of the true role of SMBG. The benefits of SMBG are realized only when both the patient and the health care provider (HCP) know how and are willing to monitor, interpret, and respond appropriately to acute glucose excursions and patterns of glycemia identified through SMBG. Optimal utilization of SMBG requires that patients be trained and motivated to accurately perform SMBG at the time and frequency prescribed, accurately interpret the data they obtain, act upon the information when appropriate, and consistently document results for later review with their HCP. HCPS must be willing and able to routinely monitor SMBG data and make appropriate adjustments in therapy. Numerous studies are needed to evaluate the true value and utility of SMBG within the diverse T2DM population to ensure that resources for diabetes management can be used efficiently. This article identifies and discusses key factors to consider for the design of randomized studies that can provide a foundation upon which HCPs and health care systems may reevaluate their current strategies/protocols and incorporate the learnings into more effective approaches to patient care.
Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med.1993; 329 (14): 977–86.
2.
EvansJMNewtonRWRutaDAMacDonaldTMStevensonRJMorrisAD, Frequency of blood glucose monitoring in relation to glycaemic control: Observational study with diabetes database. BMJ.1999; 319 (7202): 83–6.
3.
MurataGHShahJHHoffmanRMWendelCSAdamKDSolvasPABokhariSUDuckworthWC; Diabetes Outcomes in Veterans Study (DOVES). Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care2003; 26 (6): 1759–63.
4.
CosterSGullifordMCSeedPTPowrieJKSwaminathanR.Self-monitoring in Type 2 diabetes mellitus: A meta-analysis. Diabet Med.2000; 17 (11): 755–61.
5.
DavidsonMBCastellanosMKainDDuranP.The effect ofself monitoring of blood glucose concentrations on glycatedhemoglobin levels in diabetic patients not taking insulin: A blinded, randomized trial. Am J Med.2005; 118 (4): 422–5.
6.
FontbonneABillaultBAcostaMPercheronCVarennePBesseAEschwegeEMonnierLSlamaGPassaP.Is glucoseself-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabete Metab.1989; 15 (5): 255–60.
7.
AllenBTDeLongERFeussnerJR, Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetesmellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care.1990; 13 (10): 1044–50.
8.
SchwedesUSieboldsMMertesG.Meal-related structuredself-monitoring of blood glucose: Effect on diabetes controlin non-insulin-treated type 2 diabetic patients. Diabetes Care.2002; 25 (11): 1928–32.
9.
MorelandECVolkeningLKLawlorMTChalmersKAAndersonBJLaffelLM, Use of a blood glucose monitoringmanual to enhance monitoring adherence in adults with diabetes: A randomized controlled trial. Arch Intern Med.2006; 166 (6): 689–95.
10.
JansenJP, Self-monitoring of glucose in type 2 diabetes mellitus: A Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin.2006; 22 (4): 671–81.
11.
SarolJNNicodemusNATanKMGravaMB, Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: A meta-analysis (1966–2004). Curr Med Res Opin.2005; 21 (2): 173–84.
12.
KarterAJAckersonLMDarbinianJAD'AgostinoRBJr.FerraraALiuJSelbyJV, Self-monitoring of blood glucose levelsand glycemic control: The Northern California Kaiser Permanente Diabetes registry. Am J Med.2001; 111 (1): 1–9.
13.
KarterAJParkerMMMoffetHHSpenceMMChanJEttnerSLSelbyJV, Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care2006; 29 (8): 1757–63.
14.
WelschenLMBloemendalENijpelsGDekkerJMHeineRJStalmanWABouterLM, Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin. Cochrane Database Syst Rev.2005 Apr 18; (2): CD005060.
15.
CaldwellDMAdesAEHigginsJP, Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ.2005; 331 (7521): 897–900.
16.
AdesAE, A chain of evidence with mixed comparisons: Models for multi-parameter synthesis and consistency of evidence. Stat Med.2003; 22 (19): 2995–3016.
17.
LuGAdesAE, Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med.2004; 23 (20): 3105–24.
18.
DavidsonMB, The dilemma of self-monitoring of blood glucose. Diabetologia.2007; 50 (3): 497–9.
19.
MilesPEverettJMurphyJKerrD.Comparison of blood or urine testing by patients with newly diagnosed non-insulin dependent diabetes: Patient survey after randomised crossover trial. BMJ.1997; 315 (7104): 348–9.
20.
EsteyALTanMHMannK.Follow-up intervention: Its effect on compliance behavior to a diabetes regimen. Diabetes Educ.1990; 16 (4): 291–5.
21.
KwonHSChoJHKimHSSongBRKoSHLeeJMKimSRChangSAKimHSChaBYLeeKWSonHYLeeJHLeeWCYoonKH, Establishment of blood glucose monitoring system using the internet. Diabetes Care.2004; 27 (2): 478–83.
22.
IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation 2. http://wwwidforg.
23.
MorrisLRMcGeeJAKitabchiAE, Correlation between plasma and urine glucose in diabetes. Ann Intern Med.1981; 94 (4 Pt 1): 469–71.
24.
HarrisMI, Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care.2001; 24 (6): 979–82.
25.
BlondeLGinsbergBHHornSHirschIBJamesBMulcahyKNettlesASmoutRWrightH.Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care.2002; 25 (1): 245–6.
26.
FarmerAWadeAFrenchDPGoyderEKinmonthALNeilA.The DiGEM trial protocol-a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]. BMC Fam Pract. Jun 16; 6: 25.
27.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet1998; 352 (9131): 837–53.
28.
StrattonIMAdlerAINeilHAMatthewsDRManleySECullCAHaddenDTurnerRCHolmanRR, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ.2000; 321 (7258): 405–12.
29.
BrownJBNicholsGA, Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care.2003; 9 (3): 213–7.
30.
HirschIB, Glycemic variability: It's not just about A1C anymore!Diabetes Technol Ther.2005; 7 (5): 780–3.
31.
WingRREpsteinLHNowalkMPScottNKoeskeRHaggS.Does self-monitoring of blood glucose levels improvedietary compliance for obese patients with type II diabetes?Am J Med.1986; 81 (5): 830–6.
32.
MonnierLLapinskiHColetteC.Contributions of fasting andpostprandial plasma glucose increments to the overall diurnalhyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c). Diabetes Care.2003; 26 (3): 881–5.
33.
DavidsonJ.Strategies for improving glycemic control: Effective use of glucose monitoring. Am J Med.2005 Sep; 118 (Suppl 9A): 27S–32S.
34.
MuchmoreDBSpringerJMillerM.Self-monitoring of blood-glucose in overweight type 2 diabetic patients. Acta Diabetol.1994; 31 (4): 215–9.
35.
RuttenGvan EijkJde NobelEBeekMvan der VeldenH. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract.1990; 7 (4): 273–8.
36.
GuerciBDrouinPGrangeVBougneresPFontainePKerlanVPassaPThivoletChVialettesBCharbonnelB; ASIA Group. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab.2003; 29 (6): 587–94.
37.
JaberLAHalapyHFernetMTummalapalliSDiwakaranH.Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother.1996; 30 (3): 238–43.
38.
BrownSAGarciaAAKouzekananiKHanisCL, Culturallycompetent diabetes self-management education for MexicanAmericans: The Starr County border health initiative. Diabetes Care.2002; 25 (2): 259–68.
